A point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system, has a rapid turnaround time (approximately 15 min), and provides actionable information that can lead to a change in patient management.
Scope of the Report:
This report studies the Point Of Care Infectious Disease Market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Point of Care Infectious Disease market by product type and applications/end industries.
The global Point of Care Infectious Disease market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Point of Care Infectious Disease.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Point of Care Infectious Disease Market Segment by Companies, this report covers
Hoffmann-La Roche Ltd
Quest Diagnostics, Inc
BD & Company
Chembio Diagnostics Inc
Bio-Rad Labs Inc.
Thermo Fisher Scientific Inc
Sight Diagnostics Ltd.
Request a sample of this report @
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Clostridium difficile POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
TB and drug-resistant TB POC
Market Segment by Applications, can be divided into
Assisted Living Healthcare Facilities
Purchase copy of this Report @
Some Points from TOC:
Chapter One: Point of Care Infectious Disease Market Overview
Chapter Two: Manufacturers Profiles
Chapter Three:Global Point of Care Infectious Disease Market Competition, by Players
Chapter Four: Global Point of Care Infectious Disease Market Size by Regions
Chapter Five: North America Point of Care Infectious Disease Revenue by Countries
Chapter Six: Europe Point of Care Infectious Disease Revenue by Countries
Chapter Seven: Asia-Pacific Point of Care Infectious Disease Revenue by Countries
Chapter Eight: South America Point of Care Infectious Disease Revenue by Countries
Chapter Nine: Middle East and Africa Revenue Point of Care Infectious Disease by Countries
Chapter Ten: Global Point of Care Infectious Disease Market Segment by Type
Chapter Eleven: Global Point of Care Infectious Disease Market Segment by Application...Continued
www.arcognizance.com is an initiation in this new era of “analysis @ thought.” We are on a mission to replace the conventional research programs and give way to the latest methods and information for the organizations. We have created this hub of analytical research papers where you can get an access to the latest and the best research papers coming out from some reliable and budding research houses. After the advent of “new analytics" based on the data collection facilities of big data, the face of "business research facilities" has changed drastically. With ARC our experts have created a bookshelf where you can check out the research reports that are an outcome of the progression of knowledge in various industry sectors. Alongside you can also check some research papers, market reports, and forecasts that are talking about the "out of the box" developments in the market.
Name: Matt Wilson
Email: Send Email
Organization: Analytical Research Cognizance
Address: 100 Church street, 8th floor, Manhattan, New york, 10007
Phone: +1 (646) 434-7969
Release ID: 407958